Skip to content
★ Sign in to follow
MP

Michael P. Stansky

Board Director
Director
TriSalus Life Sciences, Inc.MAKO Surgical Corp.
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
9
Companies
2
▲ Purchases (5 ops.)
€2.9M
▼ Sales (0 ops.)
—

Latest filing published 15 May 2026 for TriSalus Life Sciences, Inc..

Filing timeline

BuySale
Michael P. Stansky

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
0%
Median T+90
-39.5%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Michael P. Stansky: trading record in brief

Michael P. Stansky, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in MAKO Surgical Corp. and TriSalus Life Sciences, Inc. Over a trading history stretching from 20 February 2008 to 14 May 2026, the count stands at 9 filings.

No open-market sale appears; the market trades are 5 purchases worth €2.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. Since January 2026: 2 purchases and no sales on the market.

A typical purchase (the median) is worth €406k.

The record was last updated on 15 May 2026 with a share grant in TriSalus Life Sciences, Inc. The latest purchase dates back some time: it was published 258 days ago, on 23 February 2026. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Michael P. Stansky

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations